Earnings History Data for Treace Medical Concepts, Inc. (TMCI) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Treace Medical Concepts, Inc.
Treace Medical Concepts Inc. is a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus. Treace Medical Concepts Inc. is based in PONTE VEDRA, Fla.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
27-02-2024 | AH | TMCI | Treace Medical Concepts, Inc. | 878.88 | -0.10 | -0.09 | -0.08 | Treace Medical Concepts Non-GAAP EPS of -$0.10 misses by $0.01, revenue of $62.2M beats by $1.97M [2/27/2024 4:32 PM] |
13.55 | -0.83 (-5.77%) |
12.50 | -1.88 (-13.07%) |
5.27 - 27.97 | 1,122,013 | 430,000 | 4,194 | ||
09-11-2023 | AH | TMCI | Treace Medical Concepts, Inc. | 685.61 | -0.28 | -0.26 | -0.22 | Treace Medical Concepts Non-GAAP EPS of -$0.28 misses by $0.02, revenue of $40.8M misses by $1.26M [11/9/2023 4:38 PM] |
6.21 | -3.79 (-37.95%) |
6.92 | -3.08 (-30.80%) |
5.27 - 27.97 | 7,826,944 | 540,000 | 770 | ||
08-08-2023 | AH | TMCI | Treace Medical Concepts, Inc. | 1,270 | -0.20 | -0.23 | -0.23 | Treace Medical Concepts Non-GAAP EPS of -$0.20, revenue of $42M [8/8/2023 5:15 PM] |
17.20 | -2.93 (-14.58%) |
20.18 | 0.05 (0.25%) |
17.19 - 27.97 | 1,275,353 | 310,000 | 6,948 | ||
08-05-2023 | AH | 4:05 PM ET (May 8) |
TMCI | Treace Medical Concepts, Inc. | 1,610 | -0.23 | -0.23 | -0.16 | Treace Medical Concepts GAAP EPS of -$0.23 in-line, revenue of $42.2M beats by $2.95M [5/8/2023 4:20 PM] |
25.03 | -0.94 (-3.62%) |
22.75 | -3.22 (-12.40%) |
12.48 - 27.97 | 966,174 | 280,000 | 1,006 | |
07-03-2023 | AH | 4:05 PM ET (Mar 7) |
TMCI | Treace Medical Concepts, Inc. | 1,360 | -0.08 | -0.13 | -0.12 | Treace Medical Concepts Non-GAAP EPS of $0.08 beats by $0.22, revenue of $49.8M beats by $4.97M [3/7/2023 5:27 PM] |
24.48 | 4.25 (21.01%) |
23.70 | 3.47 (17.15%) |
12.48 - 26.50 | 1,069,584 | 370,000 | 7,208 | |
08-11-2022 | AH | 4:05 PM ET (Nov 8) |
TMCI | Treace Medical Concepts, Inc. | 1,220 | -0.22 | -0.28 | -0.12 | Treace Medical Concepts GAAP EPS of -$0.22 beats by $0.07, revenue of $33.1M beats by $3.03M [11/8/2022 5:04 PM] |
21.48 | 1.03 (5.04%) |
20.45 | 0.0 (0.00%) |
12.48 - 25.02 | 485,101 | 270,000 | 4,772 | |
09-08-2022 | AH | 4:05 PM ET (Aug 9) |
TMCI | Treace Medical Concepts, Inc. | 864.56 | -0.23 | -0.21 | -0.10 | Treace Medical Concepts reports Q2 earnings; raises FY22 guidance [8/9/2022 5:18 PM] |
19.49 | 0.92 (4.95%) |
18.57 | 0.0 (0.00%) |
12.48 - 31.02 | 421,699 | 190,000 | 1,476 | |
05-05-2022 | AH | 4:05 PM ET (May 5) |
TMCI | Treace Medical Concepts, Inc. | 1,080 | -0.16 | -0.20 | -0.07 | Treace Medical Concepts GAAP EPS of -$0.16, revenue of $29.05M [5/5/2022 4:54 PM] |
16.32 | -1.69 (-9.38%) |
18.01 | 0.0 (0.00%) |
15.00 - 37.17 | 626,044 | 240,000 | 986 | |
|
||||||||||||||||||
03-03-2022 | AH | 4:05 PM ET (Mar 3) |
TMCI | Treace Medical Concepts, Inc. | 1,150 | -0.12 | 0.00 | 0.00 | Treace Medical Concepts GAAP EPS of -$0.12 misses by $0.11, revenue of $33.44M beats by $1.19M [3/3/2022 4:23 PM] |
20.50 | 0.09 (0.42%) |
20.41 | 0.0 (0.00%) |
15.00 - 37.17 | 195,481 | 180,000 | 612 | |
|
||||||||||||||||||
04-11-2021 | AH | 4:05 PM ET (Nov 4) |
TMCI | Treace Medical Concepts, Inc. | 1,240 | -0.12 | -0.12 | 0.00 | Treace Medical Concepts EPS in-line, beats on revenue [11/4/2021 5:37 PM] |
23.82 | -0.41 (-1.69%) |
24.23 | 0.0 (0.00%) |
19.18 - 37.17 | 444,289 | 310,000 | 488 | |
05-08-2021 | AH | 4:05 PM ET (Aug 5) |
TMCI | Treace Medical Concepts, Inc. | 1,540 | -0.10 | -0.12 | 0.00 | Treace Medical Concepts EPS beats by $0.02, beats on revenue [8/5/2021 4:58 PM] |
27.35 | -0.77 (-2.74%) |
28.12 | 0.0 (0.00%) |
24.25 - 37.17 | 142,476 | 170,000 | 273 | |
25-05-2021 | AH | After the close (May 25) |
TMCI | Treace Medical Concepts, Inc. | 1,470 | -0.07 | -0.08 | 0.00 | Treace Medical Concepts EPS in-line, beats on revenue [5/25/2021 4:24 PM] |
29.69 | 1.61 (5.71%) |
29.00 | 0.91 (3.24%) |
24.25 - 34.47 | 279,519 | 230,000 | 180 | |